You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 22, November 24, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  LETTERS
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Similarity of Drug Names

David S. Svahn, MD
The Mary Imogene Bassett Hospital Cooperstown, NY

JAMA. 1978;240(22):2433.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

A plea is often made for the use of generic names to avoid confusion among brand-name "spellalikes." I have had a recent experience that indicates that confusion may arise from the use of generic names as well. Having prescribed clonidine for hypertension and having seen no results over several months, I discovered that the patient had been given quinidine. The lesson is this: any drug, whether prescribed generically or by brand name, should be spelled clearly—especially when relatively new agents are prescribed. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.